Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02153931 · ClinicalTrials.gov registry record

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
33
Enrollment target

NCT02153931: Completed study, sponsored by National Cancer Institute (NCI).

NCT02153931 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02153931 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
33 participants
Enrollment target

Study Summary

Background: \- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1). Objective: \- To see if an ISG for parents with a child with NF1 can give the parents more social support and less anxiety. Eligibility: \- Adults age 18 and older with a child (age 0 25 years) with NF1. Design: * Participants will register for the study on a website hosted by the Children s Tumor Foundation. * Participants will complete 5 questionnaires. These will be about their emotional well-being, their child s health status, and their contact information. * The ISG will include a Discussion Forum that participants can enter 24 hours a day, 7 days a week. A professional moderator will post questions and discussion topics. The moderator can also respond to questions. They will be a psychologist, a psychology associate, or a nurse-practitioner. Each one will be highly experienced at working with young people with NF1 and their families. * The ISG also will contain a chat room. Here participants can chat with other users in real time. The chat room will be open for one 90-minute session per week. * The ISG will remain open for 8 weeks. Then participants will retake 4 of the questionnaires from the beginning of the study. They will also complete 1 other questionnaire about their experiences with the ISG. Information from any messages participants post on the ISG website will be collected. * Three months after the ISG closes, participants will complete the questionnaires one final time.

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2014-05-31
Est. Completion 2019-01-29

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT02153931

The ClinicalTrials.gov registry entry for NCT02153931 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02153931 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02153931 about?

NCT02153931 is a clinical study titled "Internet Support Group for Parents of a Child With Neurofibromatosis Type 1". Background: \- Studies show that Internet Support Groups (ISGs) can help parents of children with chronic conditions. Researchers want to find out if ISGs can help parents of a child with the genetic disorder Neurofibromatosis Type 1 (NF1). Objective: \- To see if an ISG for parents with a child ...

What is the current status of trial NCT02153931?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2014-05-31. Estimated completion is 2019-01-29.

Who is sponsoring clinical trial NCT02153931?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.